Nightfood Holdings Advances Robotics Deployment in Sterile Pharmaceutical Manufacturing

June 17th, 2026 1:45 PM
By: Newsworthy Staff

Nightfood Holdings through TechForce Robotics deploys PUR-E autonomous clean room robot at SAPU Bio's sterile facility, expanding robotics into regulated pharmaceutical manufacturing.

Nightfood Holdings Advances Robotics Deployment in Sterile Pharmaceutical Manufacturing

Nightfood Holdings Inc. (OTCQB: NGTF), operating through its TechForce Robotics subsidiary, has announced the advancement of Phase 2 objectives under its joint development collaboration with Oncotelic Therapeutics (OTCQB: OTLC). The milestone is marked by the deployment of PUR-E, an autonomous clean room support robot, within SAPU Bio’s OEB-5 sterile injectable cGMP facility. This deployment expands the initiative beyond Phase 1 materials logistics operations into sterile manufacturing and clean room environments, where TechForce and Oncotelic are evaluating robotics, automation and AI-driven technologies to support regulated pharmaceutical workflows.

PUR-E joins TechForce’s LIM-E autonomous GMP support robot at the SAPU Bio facility. The systems are being used to assess opportunities in sterile manufacturing operations, electronic batch record processes and other cGMP activities. According to the companies, the initiative is part of a broader effort to develop robotics and automation solutions for pharmaceutical manufacturing, biotechnology and life sciences environments. PUR-E operates as part of TechForce’s Robotics-as-a-Service Provider (RaaSP) platform, which offers flexible, scalable automation solutions while generating recurring revenue opportunities.

The deployment signals a significant step toward integrating autonomous systems into highly regulated environments, where precision and contamination control are critical. By automating routine tasks in clean rooms, the technology aims to improve operational efficiency, workflow consistency, and labor optimization. The collaboration between TechForce and Oncotelic underscores the growing interest in leveraging robotics and AI to address labor challenges and productivity demands in the pharmaceutical sector.

Nightfood Holdings, doing business as TechForce Robotics, is an AI-enhanced robotics and automation company focused on developing, integrating, deploying, and commercializing intelligent automation solutions across multiple industries. Through its TechForce Robotics platform, the company develops and deploys autonomous robotic systems designed to improve operational efficiency, workflow consistency, labor optimization, and scalability across hospitality, foodservice, commercial, laboratory, pharmaceutical, and emerging enterprise automation environments.

The company delivers its solutions through a Robotics-as-a-Service (RaaS) model, providing customers with flexible, scalable automation solutions while generating recurring revenue. As it expands into pharmaceutical automation, laboratory automation, industrial automation, and other high-precision applications, TechForce continues to leverage strategic partnerships and advanced engineering capabilities to accelerate innovation and commercialization across multiple high-growth markets.

For more information on the press release, visit https://ibn.fm/mXU1p. To view the latest news and updates relating to NGTF, visit the company’s newsroom at http://ibn.fm/NGTF.

Source Statement

This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,

blockchain registration record for the source press release.
;